Friday, May 2, 2014

BioProcess International Awards: Most Effective Licensing or Comarketing Agreement

The 2014 BioProcess International Awards celebrate and recognize the outstanding people, organizations and technologies that have significantly changed, impacted, and advanced the efficiency of biotherapeutic development and manufacturing process ultimately allowing the industry to deliver better, more effective treatments to a global patient base.  We're accepting nominations through June 27, 2014.   In the weeks leading up to the nomination deadline, we'll be spotlighting many of the award categories here. Visit the webpage to find out more.

Today, we spotlight the award for:

Most Effective Licensing or Comarketing Agreement

In contrast with formal corporate partnerships and collaborations, technology licensing agreements can protect an owner’s intellectual property while enabling its licensees to accelerate development and meet shorter term financial goals — often helping sustain the licensee during longer-term development of a lead candidate. Such arrangements may apply to licensing of a cell-line or media supplement, enabling company start-ups (such as diagnostic testing labs) in emerging regions, or make available proprietary software and/or automated systems and databases. These and other creative licensing or marketing approaches have the potential to example the biopharmaceutical industry around the globe while reducing the eventual cost to patients.

The BioProcess International Awards will be handed out this October at the BioProcess International event in Boston.  If you have any questions, feel free to reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment